Cell-surface sialic acid residue

Cell-surface sialic acid residues are **terminal nine-carbon monosaccharides** (derivatives of neuraminic acid) covalently attached to the ends of glycan chains on glycoproteins and glycolipids found on the outer membrane of nearly all animal cells[1][2][3][4]. They are not free molecules or receptors themselves but represent a class of post-translational sugar modifications. These negatively charged residues confer hydrophilicity and a net negative charge, influencing cellular repulsion, fluid uptake, and protection against complement-mediated lysis[1][4][5]. Functionally, they participate in **cell-cell recognition, immune modulation (e.g., via selectins and siglecs), and protection from innate immune molecules** such as mannose-binding lectin[1][2][3][5]. In pathology, aberrant or hypersialylation is frequently observed in cancers, contributing to tumor immune evasion and metastatic processes, and also plays roles in viral (influenza) and bacterial pathogenesis via molecular mimicry and as viral attachment sites[3][5]. Sialic acid–recognizing proteins and enzymes (such as neuraminidases/sialidases) also play therapeutic roles, especially in the context of viral infection (influenza, targeted by neuraminidase inhibitors)—but the cell-surface sialic acid residue itself is *not* a classical receptor, enzyme, or single druggable protein, and thus is not a direct therapeutic target but rather a functional group or motif targeted indirectly[3][4][5].

Other names

Sialic acidSialylated glycanTerminal sialic acidsSialyl residue

Inhibition of viral neuraminidase (prevents release of influenza virus); Disruption or targeting of aberrant sialylation in cancer therapy; Masking or exposure of underlying cell-surface molecules (e.g., unmasking antigens)